Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Cardiol. Dec 26, 2012; 4(12): 341-346
Published online Dec 26, 2012. doi: 10.4330/wjc.v4.i12.341
Table 1 Baseline criteria of all patients
Total (n = 55)GroupI(n = 35)Group II (n = 20)P value
Age59.4 ± 13.661.0 ± 9.957.7 ± 16.90.4
Gender, n (%)0.8
Male29 (72.5%)14 (70%)15 (75%)
Female11 (27.5%)6 (30%)5 (25%)
IVS (mm)10.3 ± 2.49.4 ± 2.111.3 ± 2.40.01
PW (mm)9.8 ± 1.79.4 ± 1.510.2 ± 1.90.1
LV mass245.4 ± 99.5254.9 ± 108.9235.3 ± 90.60.5
LA diameter (mm)38.3 ± 6.640.2 ± 6.436.3 ± 6.30.07
LVDD (mm)51.2 ± 9.855.2 ± 11.649.0 ± 5.10.009
LVSD (mm)36.4 ± 11.941.3 ± 14.130.2 ± 5.30.008
LV-FS (%)30.0 ± 11.126.4 ± 11.934.9 ± 7.10.03
LVDV (mL)119.4 ± 65.7137.9 ± 85.899.9 ± 20.80.07
LVSV (mL)65.7 ± 60.887.3 ± 77.340.9 ± 20.10.02
LV-EF (%)49.9 ± 15.041.9 ± 14.159.7 ± 8.10.0001
WM score20.6 ± 6.424.9 ± 6.416.0 ± 0.00.0001
WM score index1.3 ± 0.41.6 ± 0.41.0 ± 0.00.0001
Global LS-11.8 ± 6.7-9.3 ± 7.1-15.6 ± 3.70.02